In the backdrop of fresh outbreak of Covid-19 in China, there has been an increase in the prices of active pharma ingredients – the components used to manufacture drugs – for Covid medicines like paracetamol, azithromycin and others.
The APIs associated with Covid drugs have become costlier by 15-20 percent in a week. The Indian pharma industry is dependent on China for key starting materials (KSMs) for several APIs.
India has started manufacturing many of the APIs in the last three years, but the industry is still dependent on China for key starting materials (KSMs) for several APIs
Also Read: BJP’s Gujarat Win To Have “Positive Impact” On 2024 Elections, says Amit Shah
